Triazine angiogenesis inhibitors

Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting an...

Full description

Saved in:
Bibliographic Details
Main Authors DONALD J. DAVIDSON, KEITH W. WOODS, JACK HENKIN, GEORGE S SHEPPARD, RICHARD W. MCCROSKEY
Format Patent
LanguageEnglish
Published 05.07.1999
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal.
AbstractList Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal.
Author DONALD J. DAVIDSON
RICHARD W. MCCROSKEY
GEORGE S SHEPPARD
JACK HENKIN
KEITH W. WOODS
Author_xml – fullname: DONALD J. DAVIDSON
– fullname: KEITH W. WOODS
– fullname: JACK HENKIN
– fullname: GEORGE S SHEPPARD
– fullname: RICHARD W. MCCROSKEY
BookMark eNrjYmDJy89L5WRQCCnKTKzKzEtVSMxLz8xPT81LLc4sVsjMy8hMyizJLyrmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyUAtJfGOoYYWhhamlpaOxoRVAADO6Sba
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 6
ExternalDocumentID AU1818599A
GroupedDBID EVB
ID FETCH-epo_espacenet_AU1818599A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:54:02 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU1818599A3
Notes Application Number: AU1818599
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990705&DB=EPODOC&CC=AU&NR=1818599A
ParticipantIDs epo_espacenet_AU1818599A
PublicationCentury 1900
PublicationDate 19990705
PublicationDateYYYYMMDD 1999-07-05
PublicationDate_xml – month: 07
  year: 1999
  text: 19990705
  day: 05
PublicationDecade 1990
PublicationYear 1999
RelatedCompanies ABBOTT LABORATORIES
RelatedCompanies_xml – name: ABBOTT LABORATORIES
Score 2.5051906
Snippet Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Triazine angiogenesis inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990705&DB=EPODOC&locale=&CC=AU&NR=1818599A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB2VgoAbFFDZc0C5WSSNsx0q1GZRhdRFKEW9VXbqtL6kFQni9xmHBLj0ZtnSeJFnxs_2vAF48j3GHMtMid8TnNCMpsQzbUYsbjoIOHxmrdR9x3jijOb0dWEvWrBpYmEqntCvihwRNSpFfS8re737u8QKq7-VxTOXWLV9iZN-qK_qcDGEeoath8N-NJuG00APAkSS-uQNlRwdk-8PDuBQHaIVy370PlQxKbv_DiU-g6MZysrLc2iJvAMnQZN3rQPH4_q5G4u15hUXoCW4UxQTtMbytdyulYmShSbzjeRSZcy5hMc4SoIRwa6Wv7NaDubNmKwraCPWF13Q3J7wBOWWZ6QGpYocLHMYyxwjo-7Ko_Y1dPdJudnfdAunP2wDLjHsO2iXH5_iHn1pyR-qZfgGCaV41Q
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4gGvGmqMEnPZjeGlu6fR2IgZamKi3EFMONbF-wl0JsjX_f6dqqF26b3WT2kZ2ZfLM73wA8WCaluqrEkjVII4lkJJZMRaOSGik6Ag6LqkkV7_AD3VuQl6W2bMGmyYXhPKFfnBwRNSpGfS-5vd79BbEc_reyeIwYdm2f3HDoiEmdLoZQT9ZEZzyczGfOzBZtG5GkGLyhkqNjsqzRARwaCAg5UHofVzkpu_8OxT2FoznKysszaKV5Fzp2U3etC8d-_dyNzVrzinMQQrwpFRO0QPM1264rE8UKgeUbFrGqYs4F9N1JaHsSTrX63dVqtGjWpF5CG7F-2gPBGKRmSiLVlGOZkIocLNMpzXQ5I0ZiEu0KevukXO8f6kPHC_3pavocvN7AyQ_zgCHJ2i20y4_P9A79ahnd8yP5BtOoe78
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Triazine+angiogenesis+inhibitors&rft.inventor=DONALD+J.+DAVIDSON&rft.inventor=KEITH+W.+WOODS&rft.inventor=JACK+HENKIN&rft.inventor=GEORGE+S+SHEPPARD&rft.inventor=RICHARD+W.+MCCROSKEY&rft.date=1999-07-05&rft.externalDBID=A&rft.externalDocID=AU1818599A